Perioperative Management of Chronic Antithrombotic Agents in Elective Hip and Knee Arthroplasty
Authors:
Open Access
Abstract
Total hip and knee arthroplasty are common major orthopedic operations being performed on an increasing number of patients. Many patients undergoing total joint arthroplasty (TJA) are on chronic antithrombotic agents due to other medical conditions, such as atrial fibrillation or acute coronary syndrome. Given the risk of bleeding associated with TJAs, as well as the risk of thromboembolic events in the post-operative period, the management of chronic antithrombotic agents perioperatively is critical to achieving successful outcomes in arthroplasty. In this review, we provide a concise overview of society guidelines regarding the perioperative management of chronic antithrombotic agents in the setting of elective TJAs and summarize the recent literature that may inform future guidelines. Ultimately, antithrombotic regimen management should be patient-specific, in consultation with cardiology, internal medicine, hematology, and other physicians who play an essential role in perioperative care.Keywords
This publication has 57 references indexed in Scilit:
- Continuing Clopidogrel During Elective Total Hip and Knee Arthroplasty: Assessment of Bleeding Risk and Adverse OutcomesThe Journal of Arthroplasty, 2014
- Prevention of VTE in Orthopedic Surgery PatientsChest, 2012
- Perioperative Management of Antithrombotic TherapyChest, 2012
- Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended ProphylaxisJAMA, 2012
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial FibrillationChest, 2010
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based ApproachChest, 2010
- Prevention of Venous ThromboembolismChest, 2008
- Selecting Patients With Atrial Fibrillation for AnticoagulationCirculation, 2004
- Pulmonary Embolism Mortality in the United States, 1979-1998Archives of internal medicine (1960), 2003
- PREVENTION OF DEEP-VEIN THROMBOSIS BY LOW-DOSE HEPARIN IN PATIENTS UNDERGOING TOTAL HIP REPLACEMENTThe Lancet, 1974